Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 5/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 5/20 | 0.50 |
| ▸ | RELA | Q04206 | 5/20 | 0.50 |
| ▸ | BTK | Q06187 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1661965 | 1.00 | GAA (0.55) | GAANFKB1NFKB2RELABTK | |
| SCHEMBL1661966 | 1.00 | GAA (0.55) | GAANFKB1NFKB2RELABTK | |
| SCHEMBL10054766 | 0.86 | GAA (0.51) | GAANFKB1NFKB2RELABTK | |
| SCHEMBL7801965 | 0.84 | GAA (0.37) | GAANFKB1NFKB2RELA | |
| SCHEMBL7403132 | 0.84 | GAA (0.37) | GAANFKB1NFKB2RELA | |
| SCHEMBL7403136 | 0.84 | GAA (0.37) | GAANFKB1NFKB2RELA | |
| SCHEMBL29217279 | 0.84 | GAA (0.52) | GAANFKB1NFKB2RELABTK | |
| SCHEMBL19021605 | 0.84 | GAA (0.52) | GAANFKB1NFKB2RELABTK | |
| SCHEMBL14159811 | 0.79 | GAA (0.51) | GAANFKB1NFKB2RELABTK | |
| SCHEMBL14308598 | 0.78 | GAA (0.47) | GAANFKB1NFKB2RELABTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085531-A | Antibacterial injectable hydrogel | 南方医科大学南方医院 | 2024-05-28 | — | — | CN | claimed |
| CN-118021716-A | PH sensitive antibacterial hydrogel for injection | 南方医科大学珠江医院 | 2024-05-14 | — | — | CN | claimed |
| CN-118085531-A | Antibacterial injectable hydrogel | 南方医科大学南方医院 | 2024-05-28 | — | — | CN | disclosed |
| CN-118085531-A | Antibacterial injectable hydrogel | 南方医科大学南方医院 | 2024-05-28 | — | — | CN | disclosed |
| CN-118063491-A | Imide catalyst auxiliary agent, polyimide film and preparation method | 中国科学院化学研究所 | 2024-05-24 | — | — | CN | disclosed |
| CN-118021716-A | PH sensitive antibacterial hydrogel for injection | 南方医科大学珠江医院 | 2024-05-14 | — | — | CN | disclosed |
| CN-118021716-A | PH sensitive antibacterial hydrogel for injection | 南方医科大学珠江医院 | 2024-05-14 | — | — | CN | disclosed |
| CN-117024476-A | diphenylphosphonooxy-X-phenol compound, preparation method and application in preparation of aspartame | 西北工业大学 | 2023-11-10 | — | — | CN | disclosed |
| US-6008058-A | SYNTHESIZING AND SCREENING CYCLIC PEPTIDE LIBRARIES | UNIVERSITY OF LOUISVILLE (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0638068-B1 | PROCESS FOR THE MANUFACTURE OF (S)-3-AMINO-1-SUBSTITUTED-PYRROLIDINES | WARNER LAMBERT CO (US) | 1999-06-23 | — | — | EP | disclosed |
| EP-0911322-A2 | 1-Benzyl-3-(S)-[2-(S)-(tert-butoxy-carbonylamino) propionylamino] -pyrrolidine and its use as an intermediate | WARNER-LAMBERT COMPANY (US) | 1999-04-28 | — | — | EP | disclosed |
| CN-1032212-C | N-protected alpha-L-aspartyl-L-methyl phenylalaninate | MITSUI TOATSU CHEMICALS (JP) | 1996-07-03 | — | — | CN | disclosed |
| EP-0638068-A1 | PROCESS FOR THE MANUFACTURE OF (S)-3-AMINO-1-SUBSTITUTED-PYRROLIDINES | WARNER-LAMBERT COMPANY (US) | 1995-02-15 | — | — | EP | disclosed |
| EP-0334236-B1 | Preparation of n-protected alpha-l-aspartyl-l-phenylalanine methyl ester | MITSUI TOATSU CHEMICALS (JP) | 1994-08-31 | — | — | EP | disclosed |
| US-5302743-A | Reacting N-protected L-aspartic anhydride with L-phenylalanine methyl ester salt in non-aqueous solvent | MITSUI TOATSU CHEMICALS, INC. (JP) | 1994-04-12 | — | — | US | disclosed |
| WO-1993022283-A1 | PROCESS FOR THE MANUFACTURE OF (S)-3-AMINO-1-SUBSTITUTED-PYRROLIDINES | WARNER-LAMBERT COMPANY (US) | 1993-11-11 | — | — | WO | disclosed |
| US-5250704-A | Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines | WARNER-LAMBERT COMPANY (US) | 1993-10-05 | — | — | US | disclosed |
| US-5177217-A | Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines | WARNER-LAMBERT COMPANY (US) | 1993-01-05 | — | — | US | disclosed |
| CN-1036581-A | N-is protected the preparation method of 2-L-aspartyl-L-phenylalanine methyl esters | MITSUI TOATSU CHEMICALS (JP) | 1989-10-25 | — | — | CN | disclosed |
| EP-0334236-A2 | Preparation of n-protected alpha-l-aspartyl-l-phenylalanine methyl ester | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-09-27 | — | — | EP | disclosed |